Cited by 189Cannabis and Cannabinoid ResearchMemory and Neural MechanismsNeuroscience and Neuropharmacology Research

Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs

Open access
Laviolette, S. R., Grace, A. A.·2006·Journal of Neuroscience

Abstract

Cannabinoids represent one of the most commonly used hallucinogenic drug classes. In addition, cannabis use is a primary risk factor for schizophrenia in susceptible individuals and can potently modulate the emotional salience of sensory stimuli. We report that systemic activation or blockade of cannabinoid CB1 receptors modulates emotional associative learning and memory formation in a subpopulation of neurons in the mammalian medial prefrontal cortex (mPFC) that receives functional input from the basolateral amygdala (BLA). Using in vivo single-unit recordings in rats, we found that a CB1 receptor agonist potentiated the response of medial prefrontal cortical neurons to olfactory cues paired previously with a footshock, whereas this associative responding was prevented by a CB1 receptor antagonist. In an olfactory fear-conditioning procedure, CB1 agonist microinfusions into the mPFC enabled behavioral responses to olfactory cues paired with normally subthreshold footshock, whereas the antagonist completely blocked emotional learning. These results are the first demonstration that cannabinoid signaling in the mPFC can modulate the magnitude of neuronal emotional learning plasticity and memory formation through functional inputs from the BLA.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.0707-06.2006

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The effects of ECBs on fear are not restricted to the BLA but involve a pathway between the BLA and mPFC.

    “These effects on fear are not restricted to the BLA but involve a pathway between the BLA and mPFC.”
  • Responses to fear cues in mPFC neurons receiving inputs from BLA were potentiated by the CB1R agonist WIN55212-2, and CB1R blockade/inverse agonism with AM251 in these regions disrupts fear learning and learning-related long-term potentiation.

    “Responses to fear cues in mPFC neurons receiving inputs from BLA were potentiated by the CB1R agonist WIN55212-2, and CB1R blockade/inverse agonism (with AM251) in these regions disrupts fear learning and learning-related synaptic plasticity (long-term potentiation) [83–85].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 52 · Cited by 189

Authors
Laviolette, S. R., & Grace, A. A.
Affiliations
University of Pittsburgh (US)
Venue
Journal of Neuroscience
Published
2006-06-14
Volume
26
Issue
24
Pages
6458-6468
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1969305409
Cited by
189
References
52
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 7 · 2020: 8 · 2019: 5 · 2018: 10 · 2017: 9 · 2016: 8 · 2015: 14 · 2014: 16 · 2013: 12 · 2012: 14
FWCI
8.77
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Alliance for Research on Schizophrenia and Depression
  • U.S. Public Health Service (DA15408)
  • Canadian Institutes of Health Research
  • National Institute of Mental Health (MH 45156, P50MH045156)
  • National Institute on Drug Abuse (DA 15408)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
cannabinoids, CB1 receptor, medial prefrontal cortex, basolateral amygdala, fear conditioning, neuroplasticity, memory formation, single-unit recording
MeSH terms
Action Potentials, Amygdala, Animals, Association Learning, Behavior, Animal, Calcium Channel Blockers, Cannabinoids, Dose-Response Relationship, Drug, Drug Interactions, Electroshock, Fear, Male, Morpholines, Naphthalenes, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Rats, Sprague-Dawley, Prefrontal Cortex, Benzoxazines, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review